MediNext Research Network is a selective Site Management Organization supporting 23 vetted research sites and 74 Principal Investigators across the United States, El Salvador, Honduras, and Ecuador. We support Phase I–IV clinical trials across 15 therapeutic specialties, but only through sites that have been evaluated and confirmed for the capabilities, experience, and commitment clinical research demands.
From regulatory management and contract negotiation to start-up coordination and ongoing operational support, we centralize everything under one team, so sponsors get consistent performance, and sites get the infrastructure to grow.